Delivery Order SPE2DB22D1103-SPE2DB24FTNU7
Award Date
7/19/24
Potential Completion Date
7/22/24
Potential Value
$6.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,565,505,318 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract, valued at $18,726.20, is a firm fixed-price delivery order with an ultimate completion date of August 20, 2024. Amerisourcebergen, through its Corporate Office Division, will supply this critical vaccine to support the healthcare needs of military...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,564,430 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10 ML vaccine. The contract has a ceiling value of $9,363.20 and is a firm fixed-price Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of May 13, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) was issued by the Defense Logistics Agency (DLA) for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. It is a firm fixed price delivery order with a ceiling value of $2,377.45 and a completion date of October 9, 2024. The contract is not set aside for any specific business category. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,563,333,803 units of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has a ceiling value of $37,452.40 and a period of performance through January 17, 2024. This is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $3,421.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the Corporate Office division of Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract is for the delivery of 4,564,403,619 units of the vaccine TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. This is a firm-fixed price delivery order contract with a performance period ending on April 26, 2024. The contract was...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is for the delivery of 4,565,164,918 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine, with a ceiling value of $2,052.60 and a completion date of July 17, 2024. The contract is a Firm Fixed Price (FFP) type and is not set aside for any specific...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $3,312.11 firm-fixed-price contract is for the supply of 4,565,364,928 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The award has an ultimate completion date of August 7, 2024. AmerisourceBergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by various defense and civilian...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,670,234 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a ceiling value of $2,879.76. The contract has a Firm Fixed Price pricing type and is a Delivery Order. The contract has an ultimate completion date of March 24, 2025. The contract does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,563,238,642 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The firm fixed-price delivery order is valued at $5,197.13 and has a completion date of January 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products to federal agencies, particularly the...
This federal contract award is for the delivery of 4,565,058,954 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine to the Defense Logistics Agency (DLA). The $27,432.44 Firm Fixed Price Delivery Order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The contract has an ultimate completion date of July 3, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...